Weekly Reads

The Niche’s recommended Weekly Reads on stem cell research and regenerative medicine.

Recommended reads: lung stem cells, Utah stem cell law, Ozzy gets cells

normal lung alveoli indicating examples at1 and at2 cells

We’ve known that most organs have resident stem cell populations for decades, but things have been less clear in the lung and it has only been relatively recently that lung stem cells have been definitively characterized. Why is so important? Lung stem cells, whether endogenous or made in the lab, have the potential to help […]

Recommended reads: lung stem cells, Utah stem cell law, Ozzy gets cells Read More »

Recommended reads: John Cleese, surprising human embryo study, stem bank scandal, reprogramming & aging

John Cleese stem cells anti-aging, John Cleese

If you remember Monty Python, then you probably recall John Cleese. We’ll start with Cleese’s stem cell baloney. Not spam. Secret to eternal youth? John Cleese extols virtues of stem cell treatment, The Guardian. I’ve written before about John Cleese’s stem cell anti-aging efforts. As I told the author of The Guardian piece, I love

Recommended reads: John Cleese, surprising human embryo study, stem bank scandal, reprogramming & aging Read More »

Recommended reads: police act on phony autism cure, Aspen starts Parkinson’s trial, reprogramming to iBlastoids

stem cells for autism

People often ask me about stem cells for autism or even their hope of an autism cure. I’ve explained that there is no new treatment for autism based on stem cells. There aren’t even mildly encouraging data. Note that it can be hurtful to the community to talk about an autism cure and disregarding neurodiversity.

Recommended reads: police act on phony autism cure, Aspen starts Parkinson’s trial, reprogramming to iBlastoids Read More »

Weekly reads: abundant Abcam prices, speedy aging & cancer, stemmy CAR-T, more on STAP

Abcam prices

When a vendor of important reagents like antibody supplier Abcam charges big money, those high Abcam prices could negatively impact research in the long run. Some of the prices are so high that buying just a few antibodies could take up a small but meaningful slice of an entire R01 grant. Sky-high Abcam prices I’ve

Weekly reads: abundant Abcam prices, speedy aging & cancer, stemmy CAR-T, more on STAP Read More »

Weekly reads: immune rejuvenation, Cryo-Cell spin-off, stem cell patches, direct reprogramming

Irv Weissman, immune rejuvenation

What is immune rejuvenation? How would that work and what would be the benefits? As we age, our immune systems can change in unhelpful and unhealthy ways. One such change is a drift in the balance of production of different kinds of immune cells. Such a shift can lead to too many of some immune

Weekly reads: immune rejuvenation, Cryo-Cell spin-off, stem cell patches, direct reprogramming Read More »

Weekly reads: heterochromatin, H3.3, Mesoblast bump

N-myc, heterochromatin

My lab is focused in part on chromatin states in stem cells and cancer including heterochromatin. In fact, my lab’s website is chromatin.com. Heterochromatin is dense, often inactive chromatin. By H&E staining and electron microscopy, heterochromatin looks dark compared to the rest of the nucleus, largely composed of euchromatin. Toward the end of my postdoc

Weekly reads: heterochromatin, H3.3, Mesoblast bump Read More »

Weekly reads: elephant stem cells, RIP Connie Eaves, AI cell biology

elephant stem cells

Last week one of the most popular stories was about a preprint from a mammoth de-extinction research group led by George Church having made elephant stem cells. I finally got a chance to look carefully at their preprint. Elephant stem cells preprint and mammoth de-extinction The elephant stem cells preprint has solid data. It looks like

Weekly reads: elephant stem cells, RIP Connie Eaves, AI cell biology Read More »

Weekly reads: anti-aging tricks & treats, stealthy stem cells, Mammoth de-extinction milestone

Pura Munoz-Canoves

Anti-aging might already be the big regenerative medicine story of 2024 and it’s only early March. Anti-aging hype going to the dogs? One of my 20 stem cell and regenerative medicine predictions for 2024 was that longevity would continue to make big news including in some not-so-great ways. In just over two months there has

Weekly reads: anti-aging tricks & treats, stealthy stem cells, Mammoth de-extinction milestone Read More »

Weekly reads: Vertex, stem cells for MS, Athersys, 900-day paper review at Nature

“While still early, these results support the continued progression of our VX-880 clinical studies, as well as future studies using our encapsulated islet cells, which hold the potential to be used without the need for immunosuppression,” said Bastiano Sanna, Ph.D., executive vice president and chief of cell and genetic therapies at Vertex.

Vertex Pharmaceuticals has a lot going for it right now on the cell therapy front. For instance, they have the strongest type 1 diabetes cell therapy pipeline after some recent acquisitions. Still it’s not a simple matter to succeed in the cell therapy space even with one therapy for one targeted disease. Trials are tough

Weekly reads: Vertex, stem cells for MS, Athersys, 900-day paper review at Nature Read More »

Weekly reads: AL embryos ruling, blasting cancer, marrow organoids, beef inside rice plants

Multipotent & totipotent vs pluripotent stem cells, very early human embryos totipotent stem cells

Are small clusters of cells that make up 5-day-old human embryos equivalent to children? Biologically and in terms of just common sense, the answer is “no.” These tiny spheres have around 100 cells and no organs. Actual people have many trillions of cells, brains, and other organs. Alabama law on embryos may block IVF About

Weekly reads: AL embryos ruling, blasting cancer, marrow organoids, beef inside rice plants Read More »

Subscribe to Our Newsletter

Be the first to know about the latest developments in stem cell and regenerative medicine research.